In a significant development for concussion assessment, Spartan Medical has formed a partnership with Headsafe US Inc., a rising star in medical technology from Australia. This collaboration aims to enhance access to Headsafe’s innovative product, Nurochek™, which offers rapid and objective concussion evaluations within a two-minute timeframe. This partnership not only solidifies Headsafe’s distribution capabilities in the U.S. but also enhances the commercialization strategy through Spartan Medical’s extensive infrastructure.
Empowering U.S. Healthcare
Spartan Medical, a veteran-owned company with a robust background in government contracting, will serve as the authorized distributor for Nurochek™ in the United States. The company’s expertise includes navigating U.S. procurement channels, particularly within the Department of Veterans Affairs (VA) and the Department of Defense (DoD). By leveraging Spartan Medical’s established distribution network, Headsafe can effectively expand its market reach and streamline product accessibility across various healthcare settings.
The Nurochek™ Advantage
Nurochek™ is a portable EEG system that aids in diagnosing concussions by delivering precise brain function data. Utilizing visual evoked potentials (VEPs), the device processes over 400,000 data points via EEG sensors integrated into a comfortable headset. Notably, Nurochek™ does not require a baseline test, allowing for immediate assessments of patients who may lack prior data. This feature is crucial in emergency situations, enabling healthcare providers to make informed decisions quickly.
A Shared Mission
Craig Corrance, CEO of Headsafe, expressed enthusiasm regarding the partnership, emphasizing how Spartan Medical provides an exceptional platform for scaling Nurochek™ throughout key U.S. healthcare channels. The collaboration is poised to deliver objective concussion assessments to clinicians who rely on timely and reliable decision-making tools.
Vince Proffitt, President of Spartan Medical, further highlighted the diverse environments where Nurochek™ can be utilized. From emergency rooms to athletic sidelines, the technology offers unprecedented value in diagnosing mild traumatic brain injuries. The personal connection to serving veterans and active service members underscores Spartan Medical’s mission to enhance safety and readiness through improved concussion diagnostics.
Expanding Clinical Access
The partnership is expected to broaden the availability of Nurochek™ across various clinical environments served by Spartan Medical’s distribution network. This includes athletic venues, emergency departments, urgent care facilities, and rehabilitation centers. By complementing Headsafe’s direct-to-market efforts, the collaboration aims to ensure that objective concussion assessments are readily accessible in critical situations.
A Proven Track Record
Spartan Medical has established itself as a reliable partner for the U.S. government and healthcare systems. The company’s leadership team brings a wealth of experience from both public and private sectors, enabling them to address complex healthcare challenges with innovative solutions. Their commitment to improving patient care, particularly for military and veteran populations, positions Spartan Medical as an ideal ally for Headsafe as they strive to enhance concussion assessment protocols.
Headsafe’s Growing Presence
Founded in Sydney, Australia, Headsafe is dedicated to revolutionizing concussion care through faster, safer, and more consistent assessment methods. Nurochek™ is a testament to this mission, serving healthcare professionals in emergency departments, neurology clinics, and sports medicine settings. With a strategic focus on U.S. operations led by Craig Corrance, Headsafe aims to facilitate real-world adoption of their technology through practical implementation and training.
Nurochek™ has received FDA clearance for use in diagnosing mild traumatic brain injury (mTBI) in patients aged 12 to 44 years, within five days of potential head injury. The device is intended for prescription use in healthcare facilities, with specific exclusion criteria ensuring patient safety.
Key Takeaways
- Strategic Partnership: Spartan Medical collaborates with Headsafe to distribute Nurochek™, enhancing concussion assessment in the U.S. healthcare market.
- Rapid Assessments: Nurochek™ delivers objective concussion evaluations in about two minutes, without requiring baseline data.
-
Focus on Safety: The technology aims to improve safety for athletes and military personnel through more accurate concussion diagnosis.
-
Diverse Applications: Nurochek™ can be utilized in various settings, from sports events to military operations, showcasing its versatility.
Conclusion
The partnership between Spartan Medical and Headsafe US Inc. marks a crucial step towards enhancing concussion care across the United States. By combining Spartan Medical’s established distribution capabilities with Headsafe’s innovative technology, the collaboration promises to deliver faster, more reliable concussion assessments to clinicians. As both companies work together, they are set to redefine standards in concussion management, ultimately benefiting patients and healthcare providers alike.
Read more → www.indystar.com